Skip to main content
  • 64 Accesses

Zusammenfassung

Der Gastrointestinaltrakt ist das größte endokrine Organ des Körpers. Seine Hormone werden aus endokrinen Zellen in der Schleimhaut des Magens, des Dünn- und Dickdarms bzw. aus dem Pankreas durch nervale Aktivität, humorale Stimuli oder durch mechanische oder chemische Reize im Rahmen der Nahrungsaufnahme freigesetzt [12, 31]. Die gastrointestinalen Hormone sind auf bestimmte für das Hormon charakteristische Bereiche des Intestinums beschränkt (Abb. 10.1). Nur Somatostatin kommt ubiquitär im Gastrointestinaltrakt vor.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

Literatur

  1. Baldwin GS (1995) The role of gastrin and cholecystokinin in normal and neoplastic gastrointestinal growth. J Gastroenterol Hepatol 10 (2): 215–232

    Article  PubMed  CAS  Google Scholar 

  2. Baldwin GS, Whitehead RH (1994) Gut hormones, growth and malignancy. [Review]. Baillieres Clin Endocrinol Metab 8 (1): 185–214

    Article  PubMed  CAS  Google Scholar 

  3. Bayliss WM, Starling EH (1902) The mechanism of pan-creatic secretion. J Physiol (London) 28: 325–353

    CAS  Google Scholar 

  4. Besson I, Ingrand P, Person B, Boutroux D, Heresbach D et al. (1995) Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med 333 (9): 555–560

    Article  PubMed  CAS  Google Scholar 

  5. Boirivant M, Fais S, Annibale B, Agostini D, Delle Fave G, Pallone F (1994) Vasoactive intestinal polypeptide modulates the in vitro immunoglobulin A production by intestinal lamina propria lymphocytes. Gastroenterology 106 (3): 576–582

    PubMed  CAS  Google Scholar 

  6. Bold RJ, Ishizuka J, Townsend CM Jr, Thompson JC (1993) Biomolecular advances in gastrointestinal hormones. Arch Surg 128 (11): 1268–1273

    PubMed  CAS  Google Scholar 

  7. Bordi C, D’Adda T, Azzoni C, Pilato FP, Caruana P (1995) Hypergastrinemia and gastric enterochromaffin-like cells. Am J Surg Pathol 19 (Suppl 1): 8–19

    Google Scholar 

  8. Bueno L, Fioramonti J (1994) Neurohormonal control of intestinal transit. Reprod Nutr Develop 34 (6): 513–525

    Article  CAS  Google Scholar 

  9. Caron P, Cogne M, Gusthiot-Joudet B, Wakim S, Catus F, Bayard F (1995) Intramuscular injections of slow-release lanreotide (BIM 23014) in acromegalic patients previously treated with continuous subcutaneous infusion of octreotide (SMS 201–995). Eur J Endocrinol 132 (3): 320–325

    Article  PubMed  CAS  Google Scholar 

  10. Chow BK (1995) Molecular cloning and functional characterization of a human secretin receptor. Biochem Biophys Res Commun 212 (1): 204–211

    Article  PubMed  CAS  Google Scholar 

  11. Crawley JN, Corwin RL (1994) Biological actions of cholecystokinin. Peptides. 15 (4): 731–755

    Article  PubMed  CAS  Google Scholar 

  12. Dietrich JB (1994) Neuropeptides, antagonists and cell proliferation: bombesin as an example. Cell Mol Biol 40 (6): 731–746

    PubMed  CAS  Google Scholar 

  13. Dimaline R, Dockray GJ (1994) Evolution of the gastrointestinal endocrine system (with special reference to gastrin and CCK). Baillieres Clin Endocrinol Metabol 8 (1): 1–24

    Article  CAS  Google Scholar 

  14. Dockray GJ (1994) The G. W. Harris Prize Lecture. The gut endocrine system and its control. [Review]. Exp Physiol 79 (5): 607–634

    PubMed  CAS  Google Scholar 

  15. Dumont Y, Martel JC, Fournier A, St-Pierre S, Quirion R (1992) Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Progr Neurobiol 38 (2): 125–167

    Article  CAS  Google Scholar 

  16. Eberlein GA, Eysselein VE, Schaeffer M et al. (1989) A new molecular form of PYY: structural characterization of human PYY(3–36) and PYY(1–36). Peptides 10: 797–803

    Article  PubMed  CAS  Google Scholar 

  17. Elahi D, McAloon-Dyke M, Fukagawa NK, Meneilly GS, Sclater AL et al. (1994) The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7–37) in normal and diabetic subjects. Regul Pept 51 (1): 63–74

    Article  PubMed  CAS  Google Scholar 

  18. Evans TC, Crittenden SL, Kodoyianni V, Kimble J (1994) Translational control of maternal glp-1 mRNA establishes an asymmetry in the C. elegans embryo. Cell 77: 183–194

    Article  PubMed  CAS  Google Scholar 

  19. Eysselein VE, Eberlein GA, Grandt D, Schaeffer M, Zehres B et al. (1990) Structural characterization of canine PYY. Peptides 11: 111–116

    Article  PubMed  CAS  Google Scholar 

  20. Fahrenkrug J (1993) Transmitter role of vasoactive intestinal peptide. Pharmacol Toxicol 72 (6): 354–363

    Article  PubMed  CAS  Google Scholar 

  21. Fehmann HC, Goke R, Goke B (1995) Cell and molecular 36. biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocr Rev 16 (3): 390–410

    PubMed  CAS  Google Scholar 

  22. Freston JW, Borch K, Brand SJ et al. (1995) Effects of 37. hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells. A review and analysis. Digest Dis Sci 40 (Suppl 2): 50S–62S

    Article  PubMed  Google Scholar 

  23. Garrett NE, Mapp PI, Cruwys SC, Kidd BL, Blake DR(1992) Role of substance P in inflammatory arthritis. Ann Rheum Dis 51 (8): 1014–1018

    Article  PubMed  CAS  Google Scholar 

  24. Glasbrenner B, Dominguez-Munoz E, Riepl RL, Vetsi A, Malfertheiner P (1995) Cholecystokinin and pancreatic 39. polypeptide release in diabetic patients with and without autonomic neuropathy. Dig Dis Sci 40 (2): 406–411

    Article  PubMed  CAS  Google Scholar 

  25. Grandt D, Burckhardt B, Schimiczek M et al. (1992) Human PYY 3–36 inhibits gastric acid secretoin (gas) in man. Regul Pept 40 (2): 158

    Article  Google Scholar 

  26. Grandt D, Layer P, Rippel K et al. (1992) Peptide YY (PYY) inhibits endogenously stimulated pancreatic enzyme secretion in man. Regul Pept 40 (2): 160

    Article  Google Scholar 

  27. Grandt D, Teyssen S, Schimiczek M, Reeve JRJ, Feth F et al. (1992) Novel generation of hormone receptor specifi-city by amino terminal processing of peptide YY. Biochem Biophys Res Commun 186: 1299–1306

    Article  PubMed  CAS  Google Scholar 

  28. Grandt D, Dahms P, Schimiczek M, Eysselein VE, Reeve JR Jr, Mentlein R (1993) Proteolytisches Processing durch Dipeptidyl-Aminopeptidase IV generiert Rezeptorselektivität für PYY (PYY). Med Klinik 88: 143–145

    CAS  Google Scholar 

  29. Guelrud M, Rossiter A, Souney PF, Rossiter G, Fanikos J, Mujica V (1992) The effect of vasoactive intestinal poly-peptide on the lower esophageal sphincter in achalasia. Gastroenterology 103 (2): 377–382

    PubMed  CAS  Google Scholar 

  30. Gutniak M, Orskov C, Holst JJ, Ahren B, Efendic S (1992) Antidiabetogenic effect of glucagon-like peptide-1 (736)amide in normal subjects and patients with diabetes mellitus. N Engl J Med 326 (20): 1316–1322

    Article  PubMed  CAS  Google Scholar 

  31. Harding RK, McDonald TJ (1989) Identification and characterization of the emetic effects of peptide YY. Peptides 10: 21–24

    Article  PubMed  CAS  Google Scholar 

  32. Hazelwood RL (1993) The pancreatic polypeptide (PP-fold) family: gastrointestinal, vascular, and feeding behavioral implications. Proc Soc Exp Biol Med 202 (1): 44–63

    PubMed  CAS  Google Scholar 

  33. Holst JJ (1994) Glucagonlike peptide 1: a newly discov-ered gastrointestinal hormone. Gastroenterology 107 (6): 1848–1855

    PubMed  CAS  Google Scholar 

  34. Holst JJ, Schmidt P (1994) Gut hormones and intestinal function. Baillieres Clin Endocrinol Metab 8 (1): 137–164

    Article  PubMed  CAS  Google Scholar 

  35. Imperiale TF, Teran JC, McCullough AJ (1995) A meta-analysis of somatostatin versus vasopressin in the management of acute esophageal variceal hemorrhage. Gastroenterology 109 (4): 1289–1294

    Article  PubMed  CAS  Google Scholar 

  36. Jiang S, Ulrich C (1995) Molecular cloning and functional expression of a human pancreatic secretin receptor. Biochem Biophys Res Commun 207 (3): 883–890

    Article  PubMed  CAS  Google Scholar 

  37. Jin HO, Song CW, Chang TM, Chey WY (1994) Roles of gut hormones in negative-feedback regulation of pancre-atic exocrine secretion in humans. Gastroenterology 107 (6): 1828–1834

    PubMed  CAS  Google Scholar 

  38. Jule Y (1993) Enkephalins and nervous system control of intestinal motility. [French]. Arch Int Physiol Biochimie Biophys 101 (4): A49–50

    Article  CAS  Google Scholar 

  39. Krenning EP, Kwekkeboom DJ, de Jong M et al. (1994) Essentials of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide. Semin Oncol 21 5 (Suppl 13): 6–14

    Google Scholar 

  40. Krenning EP, Kwekkeboom DJ, Oei HY et al. (1994) Somatostatin receptor scintigraphy in carcinoids, gastrinomas and Cushing’s syndrome. Digestion 55 (Suppl 3): 54–59

    Article  PubMed  Google Scholar 

  41. Kubota M, Nakamura T, Motokura T, Mori S, Nishida A (1994) Erythromycin improves gastrointestinal motility in extremely low birthweight infants. Acta Paediatr Jap 36 (2): 198–201

    CAS  Google Scholar 

  42. Lamberts SW, Chayvialle JA, Krenning EP (1993) The visualization of gastroenteropancreatic endocrine tumors. Digestion 54 (Suppl 1): 92–97

    Article  PubMed  Google Scholar 

  43. Liddle RA (1995) Regulation of cholecystokinin secretion by intraluminal releasing factors. Am J Physiol 269 (3Pt1): G319–327

    PubMed  CAS  Google Scholar 

  44. Liddle RA, Goldfine ID, Rosen MS, Taplitz RA, Williams JA (1985) Cholecystokinin bioactivity in human plasma: molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest 75: 1144–1152

    Article  PubMed  CAS  Google Scholar 

  45. Lieverse RJ, Jansen JB, Masclee AA, Lamers CB (1994) Role of cholecystokinin in the regulation of satiation and satiety in humans. Ann N Y Acad Sci 713: 268–272

    Article  PubMed  CAS  Google Scholar 

  46. Lu Y, Owyang C (1995) Secretin at physiological doses inhibits gastric motility via a vagal afferent pathway. Am J Physiol 268 (6Pt1): G1012–6

    CAS  Google Scholar 

  47. McCready VR, Hickish TF (1994) Somatostatin imaging function [comment]. Lancet 343 (8898): 617

    Article  PubMed  CAS  Google Scholar 

  48. Modlin IM, Basson MD (1993) Clinical applications of gastrointestinal hormones. Endocrinol Metab Clin North Am 22 (4): 823–844

    PubMed  CAS  Google Scholar 

  49. Mortazavi P, Mueller BA (1992) Erythromycin in gastrointestinal motility disturbances. Ann Pharmacother 26 (9): 1095–1097

    PubMed  CAS  Google Scholar 

  50. Muff R, Born W, Fischer JA (1995) Calcitonin, calcitonin gene-related peptide, adrenomedullin and amylin: homologous peptides, separate receptors and overlapping biological actions. Eur J Endocrinol 133 (1): 17–20

    Article  PubMed  CAS  Google Scholar 

  51. Nielsen FC, Rehfeld JF (1994) Measurement of gut hormone gene expression: mRNA and peptides. Baillieres Clin Endocrinol Metab 8 (1): 25–49

    Article  PubMed  CAS  Google Scholar 

  52. Otsuka M, Yoshioka K (1993) Neurotransmitter functions of mammalian tachykinins. Physiol Rev 73 (2): 229–308

    PubMed  CAS  Google Scholar 

  53. Patel YC, Srikant CB (1994) Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1–5). Endocrinology 135 (6): 2814–2817

    Article  PubMed  CAS  Google Scholar 

  54. Patel DR, Kong Y, Sreedharan SP (1995) Molecular cloning and expression of a human secretin receptor. Mol Pharmacol 47 (3): 467–473

    PubMed  CAS  Google Scholar 

  55. Pearson RK, Anderson B, Dixon JE (1993) Molecular biology of the peptide hormone families. Endocrinol Metab Clin North Am 22 (4): 753–774

    PubMed  CAS  Google Scholar 

  56. Pedrazzini T, Brunner HR, Waeber B (1993) Neuropeptide Y and cardiovascular regulation. Curr Opinion Nephrol Hyperten 2 (1): 106–113

    Article  CAS  Google Scholar 

  57. Peeters TL (1993) Erythromycin and other macrolides as prokinetic agents. Gastroenterology 105 (6): 1886–1899

    PubMed  CAS  Google Scholar 

  58. Peeters TL, Muls E, Janssens J, Urbain JL, Bex M et al. (1992) Effect of motilin on gastric emptying in patients with diabetic gastroparesis. Gastroenterology 102 (1): 97–101

    PubMed  CAS  Google Scholar 

  59. Pennathur A, Cioppi M, Fayad JB, Little AG (1993) Erythromycin, motilin, and the esophagus. Surgery 114 (2): 295–299

    PubMed  CAS  Google Scholar 

  60. Pennathur A, Tran A, Cioppi M, Fayad J, Sieren GL, Little AG (1994) Erythromycin strengthens the defective lower esophageal sphincter in patients with gastroesophageal reflux disease. Am J Surg 167 (1): 169–173

    Article  PubMed  CAS  Google Scholar 

  61. Redfern JS, O’Dorisio TM (1993) Therapeutic uses of gastrointestinal peptides. Endocrinol Metab Clin North Am 22 (4): 845–873

    PubMed  CAS  Google Scholar 

  62. Reeve JR Jr, Eysselein VE, Ho FJ, Chew P, Vigna SR et al. (1994) Natural and synthetic CCK-58. Novel reagents for studying cholecystokinin physiology. Ann N Y Acad Sci 713: 11–21

    Article  PubMed  CAS  Google Scholar 

  63. Schjoldager BT (1994) Role of CCK in gallbladder function. Ann N Y Acad Sci 713: 207–218

    Article  PubMed  CAS  Google Scholar 

  64. Sharkey KA (1992) Substance P and calcitonin gene-related peptide (CGRP) in gastrointestinal inflammation. Ann N Y Acad Sci 664: 425–442

    Article  PubMed  CAS  Google Scholar 

  65. Shulkes A (1994) Somatostatin: physiology and clinical applications. Baillieres Clin Endocrinol Metab 8 (1): 215–236

    Article  PubMed  CAS  Google Scholar 

  66. Simon DM, Cello JP, Valenzuela J, Levy R, Dickerson G et al. (1995) Multicenter trial of octreotide in patients with refractory acquired immunodeficiency syndrome-asso-ciated diarrhea. Gastroenterology 108 (6): 1753–1760

    Article  PubMed  CAS  Google Scholar 

  67. Spindel ER, Giladi E, Segerson TP, Nagalla S (1993) Bornbesin-like peptides: of ligands and receptors. Rec Prog Horm Res 48: 365–391

    PubMed  CAS  Google Scholar 

  68. Stanfa L, Dickenson A, Xu XJ, Wiesenfeld-Hallin Z (1994) Cholecystokinin and morphine analgesia: variations on a theme. Trends Pharmacol Sci 15 (3): 65–66

    Article  PubMed  CAS  Google Scholar 

  69. Tack J (1995) Georges Brohee Prize 1994. Motilin and the enteric nervous system in the control of interdigestive and postprandial gastric motility. Acta Gastroenterologica Belgica. 58 (1): 21–30

    CAS  Google Scholar 

  70. Taylor SD, Soudah HC, Chey WY, Scheiman JM (1994) Duodenal acidification and secretin, but not intraduodenal fat, inhibit human gastric acid secretion via prostaglandins. Gastroenterology 107 (6): 1680–1685

    PubMed  CAS  Google Scholar 

  71. Turton MD, O’Shea D, Gunn I, Beak SA, Edwards CMB et al. (1996) A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379 (6560): 69–72

    Article  PubMed  CAS  Google Scholar 

  72. Virgolini I, Raderer M, Kurtaran A, Angelberger P, Banyai S et al. (1994) Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors. N Engl J Med 331 (17): 1116–1121

    Article  PubMed  CAS  Google Scholar 

  73. Waeber G, Thompson N, Waeber B, Brunner HR, Nicod P, Grouzmann E (1993) Neuropeptide Y expression and regulation in a differentiated rat insulin-secreting cell line. Endocrinology 133: 1061–1067

    Article  PubMed  CAS  Google Scholar 

  74. Waldum HL, Brenna E, Kleveland PM, Sandvik AK (1995) Gastrin-physiological and pathophysiological role: clinical consequences. Dig Dis 13 (1): 25–38

    Article  PubMed  CAS  Google Scholar 

  75. Walsh JH (1992) Physiology and pathophysiology of gastrin. Mount Sinai J Med 59 (2): 117–124

    CAS  Google Scholar 

  76. Weber FH Jr, Richards RD, McCallum RW (1993) Erythromycin: a motilin agonist and gastrointestinal pro-kinetic agent. Am J Gastroenterol 88 (4): 485–490

    PubMed  CAS  Google Scholar 

  77. Wettstein JG, Bueno L, Junien JL (1994) CCK antagonists: pharmacology and therapeutic interest. Pharmacol Ther 62 (3): 267–282

    Article  PubMed  CAS  Google Scholar 

  78. Wettstein JG, Earley B, Junien JL (1995) Central nervous system pharmacology of neuropeptide Y. Pharmacol Ther 65 (3): 397–414

    Article  PubMed  CAS  Google Scholar 

  79. Williams JA, Blevins GT Jr (1993) Cholecystokinin and regulation of pancreatic acinar cell function. Physiol Rev 73 (4): 701–723

    PubMed  CAS  Google Scholar 

  80. Willms B, Werner J, Holst JJ, Orskov C, Creutzfeldt W, Nauck MA (1996) Gastric emptying glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7–36) amide in type 2 (noninsulin-dependent) diabetic patients. J Clin Endocrinol Metab 81 (1): 327–332

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Grandt, D., Eysselein, V., Goebell, H. (1997). Gastrointestinale Hormone. In: Stolecke, H. (eds) Endokrinologie des Kindes- und Jugendalters. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59043-6_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59043-6_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-61855-3

  • Online ISBN: 978-3-642-59043-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics